The Technology
The present patented technology describes methods and kits for diagnosing cancer. The method consists of determining the level and/or activity of at least one saliva secreted marker in a saliva sample of the subject wherein an alteration in said marker with respect to an unaffected saliva sample is indicative of cancer, with the proviso that the saliva secreted marker is not circulatory carcinoembryonic antigen (CEA).
Advantages
- Non-invasive
Applications and Opportunities
- Cancer diagnosis
- In-Vitro Diagnostics
Business Development Contacts